Incyte Corporation (INCY)
INCY price $114.08 +0.64 +0.56%
- Ticker
- INCY
- Price
- $114.08
- Change
- +0.64 +0.56%
- Market cap
- $23.12B
- P/E
- 13.95
- Forward P/E
- 35.40
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 75
Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for…